Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipoatrophy in Children, Adolescents and Adults With Modern Treatment Modalities: is There a Beneficial Effect of Insulin Glulisine?

NCT02914886 is registered in ClinicalTrials.gov with Kinderkrankenhaus auf der Bult as lead sponsor.

NCT NCT02914886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipoatrophy in Children, Adolescents and Adults With Modern Treatment Modalities: is There a Beneficial Effect of Insulin Glulisine?
Lead sponsor
Kinderkrankenhaus auf der Bult
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2016
Completion date
April 30, 2019
Enrollment
14 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lipoatrophy, type 1 diabetes